Results 91 to 100 of about 46,120 (196)

A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. [PDF]

open access: yesClin Transl Sci, 2022
Mosley SA   +20 more
europepmc   +1 more source

Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate

open access: yesClinicoEconomics and Outcomes Research, 2012
Varun Vaidya, Pranav PatelCollege of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USABackground: Metoprolol, a selective beta-1 blocker, is available in two different salt forms in the market – metoprolol succinate ...
Vaidya V, Patel P
doaj  

Robust RP-HPLC method with forced degradation studies for the simultaneous quantification of Efonidipine HCL Ethanolate and Metoprolol succinate

open access: yesDiscover Chemistry
Background A robust and validated analytical method was developed for the simultaneous quantification of Efonidipine HCl Ethanolate and Metoprolol Succinate, which show a synergistic effect against thrombocytopenia.
Priyanka Malani   +2 more
doaj   +1 more source

Stable coronary heart disease treatment: focus on beta-adrenoblockers

open access: yesКардиоваскулярная терапия и профилактика, 2008
Stable angina treatment with a prolonged-action beta-adrenoblocker, metoprolol succinate, is discussed. Themedication is effective, metabolically neutral, well tolerated and could also be used in patients with comorbidities.
V. I. Makolkin
doaj  

Formulation and Evaluation of Metoprolol Succinate Extended Release Pellets. [PDF]

open access: yes, 2012
The present study is to develop a pharmaceutically stable and quality improved formulation of Metoprolol succinate extended release pellets. To achieve this goal various prototype formulation trials were formulated and the evaluated with respect to the ...
Abhishek, P
core  

Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation. [PDF]

open access: yesClin Res Cardiol, 2022
Rivinius R   +8 more
europepmc   +1 more source

Metoprolol CR/XL: advanced formulation of a classical beta-blocker [Metoprolol CR/XL: usovershenstvovannaia forma étalonnogo beta-blokatora.]

open access: yes, 2020
Metoprolol is a selective beta(1)-adrenergic antagonist extensively used in major fields of cardiology since 1975. Metoprolol has proven its efficacy in reducing cardiovascular events and mortality in patients with hypertension and coronary heart disease
Gudkov K.M., Kobalava Z.D.
core  

Metoprolol-induced Psoriasiform Drug Eruption: A Case Report

open access: yes, 2017
Aim: We report the case of drug-induced psoriasiform eruptions in a middle aged known hypertensive and diabetic woman being treated for paroxysmal cardiac arrhythmias with metoprolol.
Umar Adamu   +6 more
core   +1 more source

EVALUATION OF EFFECTIVENESS OF MEDICATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC HEART FAILURE OF FUNCTIONAL CLASS I

open access: yesКубанский научный медицинский вестник, 2014
100 patients with CHF functional class (FC) I against the background of hypertensive disease of stage II with regular left ventricular (LV) ejection fraction (EF) (LVEF≥55%) took part in the research and were randomized into two groups. Group 1 consisted
K. S. Bondarenko
doaj  

REGULATORY ADAPTIVE STATUS IN EVALUATION OF EFFECTIVENESS OF MEDICATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE OF FUNCTIONAL CLASS III

open access: yesКубанский научный медицинский вестник, 2014
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD) who received complex therapy (quinapril, torasemide, spironolactone) took part in the research.
E. S. Rokotyanskaya
doaj  

Home - About - Disclaimer - Privacy